The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.405%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 190.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

6 Jun 2006 07:02

Synexus Clinical Research PLC06 June 2006 Synexus Clinical Research Plc ("the Company") Directorate change Synexus Clinical Research Plc is pleased to announce the appointment of MalcolmHughes (aged 52) as Non-Executive Director with immediate effect. Malcolm is currently Chief Executive of Greenman Group plc ("Greenman"), aprivate industrial company which supplies printer cartridges to European officesupplies distributors from its manufacturing base in Bulgaria. Prior toGreenman, he was Chief Executive of Oasis Healthcare Plc for four years duringwhich Oasis grew from a small regional business to become the leading dentalpractice owner/operator in the UK with turnover of over £70m. His previousexperience includes senior management roles at Chloride Group plc, LadbrokeGroup plc and Management Consulting Group plc. Commenting on the appointment, Michael Fort, chief executive of Synexus said : " I am delighted to welcome Malcolm to the Synexus board. He brings with himconsiderable knowledge and expertise, not only within the healthcare industrybut also particular experience of business operations within the emergingeconomies of Eastern Europe where Synexus has established a foothold and fromwhich we aim to expand rapidly. We look forward to benefiting from hiscontribution to the development and implementation of our growth strategy." Malcolm Hughes commented: "I am delighted to be joining Synexus at a time when it is seeking to build onits recent AIM flotation through expansion of its operations in the UK andinternationally. Its unique business model offers a strong proposition to globalpharmaceutical companies as they aim to develop more cost-effective methods oftrialling new drug treatments." Additional Information The following is a complete list of Mr Hughes' directorships as required underSchedule 2(g) of the AIM Rules: Current Previous in last 5 yearsGreenman Group plc Oasis Healthcare PlcGreenman UK Limited Oasis Dental Care LimitedGreenman Europe BV The Dencare Management Group LimitedK2 Supplies Limited Dencare Management LimitedPaprika Services Limited Dencare Financial Services LimitedBetforum UK Limited Dencare Developments Limited Dencare Implant Centres Limited Ora Dental Group Holdings Limited Ora Dental Group Limited Ora EBT Trustee Limited Inhoco 978 Limited Inhoco 979 Limited There is no further information required to be disclosed under Schedule 2(g) ofthe AIM Rules. For further information: Michael Fort, Chief Executive, Synexus Clinical Research PLC 01257 230 723 Zoe Biddick, Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Nov 20187:00 amRNSTrading Update
27th Nov 201811:29 amRNSDirector/PDMR Shareholding
29th Oct 201810:04 amRNSDirector/PDMR Shareholding
5th Oct 20187:00 amRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirectorate Change
28th Aug 20187:00 amRNSSynectics secures UK custodial sites
14th Aug 20184:00 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSInterim Results
27th Jun 20187:00 amRNSNotification of Interim Results
1st Jun 20187:00 amRNSDirectorate Change
30th May 20183:23 pmRNSHolding(s) in Company
23rd May 20187:00 amRNSContract Win
11th May 20183:38 pmRNSDirector/PDMR Shareholding
27th Apr 201811:42 amRNSDirector/PDMR Shareholding
26th Apr 20181:12 pmRNSResult of AGM
26th Apr 20187:00 amRNSAGM Statement
29th Mar 20182:09 pmRNSDirector/PDMR Shareholding
27th Mar 20184:52 pmRNSHolding(s) in Company
26th Mar 20187:00 amRNSContract Win
21st Mar 20187:01 amRNSAnnual Report and Notice of AGM
21st Mar 20187:00 amRNSDirectorate Change
20th Feb 20187:00 amRNSFinal Results
23rd Jan 20187:00 amRNSNotification of Final Results
8th Jan 20183:19 pmRNSElectronic Communication with Shareholders
4th Jan 20181:15 pmRNSHolding(s) in Company
13th Dec 20171:43 pmRNSHolding(s) in Company
12th Dec 20177:00 amRNSTrading Update
1st Dec 20175:35 pmRNSAIM Disclosure Update
30th Oct 20174:40 pmRNSDirector/PDMR Shareholding
16th Oct 20173:23 pmRNSDirector/PDMR Shareholding
22nd Sep 20173:02 pmRNSDirector/PDMR Shareholding
21st Sep 20173:58 pmRNSHolding(s) in Company
6th Sep 201710:01 amRNSDirector/PDMR Shareholding
29th Aug 20175:11 pmRNSHolding(s) in Company
18th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSNotification of Interim Results
6th Jun 20175:54 pmRNSRe-appointment of Auditor
26th May 201710:04 amRNSDirector/PDMR Shareholding
28th Apr 20174:01 pmRNSDirector/PDMR Shareholding
27th Apr 20171:08 pmRNSResult of AGM
27th Apr 20177:00 amRNSAGM Statement
11th Apr 20177:00 amRNSContract Wins
24th Mar 20172:43 pmRNSPosting of Annual Report and AGM Notice
7th Mar 20179:55 amRNSDirector/PDMR Shareholding
2nd Mar 201711:32 amRNSDirector/PDMR Shareholding
21st Feb 20177:00 amRNSFinal Results
30th Jan 20177:00 amRNSNotification of Final Results
10th Jan 20177:00 amRNSAdoption of Financial Reporting Standard 101
8th Dec 20167:00 amRNSYear End Trading Update
21st Oct 20162:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.